Keyphrases
Phencyclidine
100%
Behavior Change
100%
Receptor Activation
100%
α7 Nicotinic Acetylcholine Receptor (α7nAChR)
100%
Parvalbumin
80%
Behavioral Impairment
60%
Prefrontal Cortex
60%
MRNA Expression
60%
Schizophrenia
40%
Activity-regulated Cytoskeleton-associated Protein
40%
Symptom Relief
20%
Model Validation
20%
Cognitive Processes
20%
Partial Agonist
20%
Rodents
20%
Acute Administration
20%
Behavioral Effects
20%
Pathophysiology of Schizophrenia
20%
N-methyl-D-aspartate Receptor (NMDAR)
20%
NMDA Antagonist
20%
Patients with Schizophrenia
20%
Cognitive Deficits
20%
Agonism
20%
Deleterious Effects
20%
Neurotransmission
20%
Working Memory
20%
Polymorphism
20%
Synaptic Plasticity
20%
Interneuron
20%
Neuroscience
Phencyclidine
100%
Messenger RNA
80%
Prefrontal Cortex
80%
Parvalbumin
80%
Activity Regulated Cytoskeleton Associated Protein
40%
Synaptophysin
40%
Synaptic Plasticity
20%
Cognitive Disorder
20%
NMDA Receptor Antagonist
20%
Receptor Partial Agonist
20%
NMDA Receptor
20%
Cognitive Process
20%
Receptor Gene
20%
Interneuron
20%
Working Memory
20%
Synaptic Transmission
20%
Pharmacology, Toxicology and Pharmaceutical Science
Phencyclidine
100%
Parvalbumin
80%
1,4 diazabicyclo[3.2.2]nonane 4 Carboxylic Acid 4 Bromophenyl Ester
40%
Synaptophysin
40%
Activity Regulated Cytoskeleton Associated Protein
40%